LRMR Stock Price
Larimar Therapeutics, Inc.
$2.09
-$0.07(-3.24%)
27
Overall
60
Value
9
Tech
13
Quality
Market Cap
$217.12M
Volume
2.26M
52W Range
$2.61 - $6.42
Target Price
$14.40
LRMR stock price is $2.09 (-3.24% on the day), giving Larimar Therapeutics, Inc. a market cap of $217.12M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
LRMR Stock Overview
- Price
- $2.09
- Previous close
- $2.16
- Open
- $2.15
- Market cap
- $217.12M
- P/E ratio
- -1.3
- 52-week range
- $2.61 - $6.42
- 1-year price target
- $14.40
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 27
About Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $2.09 | -3.2% | 2.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW